Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction - sprookjes - yvandenbroek - TriplyDB

Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction

Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction

http://www.wikidata.org/entity/Q28237208

about

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes The Role of Dipeptidyl Peptidase - 4 Inhibitors in Diabetic Kidney Disease Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice.Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy.Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis.Diabetes, hypertension, and chronic kidney disease progression: role of DPP4.Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Prolonged survival by combined treatment with granulocyte colony-stimulating factor and dipeptidyl peptidase IV inhibitor in a rat small-for-size liver transplantation model.Scarless wound healing: Transitioning from fetal research to regenerative healing.Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.Murine Nephrotoxic Nephritis as a Model of Chronic Kidney Disease.Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery

P2860

Q26766089-2EEF6774-B2FE-4573-97A4-F5569A74E8D4 Q26784454-D0769401-960C-42BF-8304-77452FF053EB Q28066209-748B24CF-6A6E-4C99-8D7E-CD462F37B37D Q33883879-4B80A54F-4C52-4813-A1DB-648B50A8B7E2 Q37056839-36620824-33AC-4E48-927A-E7484B15C368 Q38404674-DA5470E8-7D10-4A46-9B46-1DF1F5A56FC0 Q39001492-97B68EC6-5C2F-4A51-9986-141B0B1659E0 Q39103371-3C08A55B-9A33-408E-81D7-D59E6921E122 Q40666037-E33737A1-7035-472A-9A36-65F31DE4F6BF Q42876331-B8F7F8B8-3D83-4455-A61B-78047B76C050 Q47439158-07EC9939-04D9-4CD3-89D0-FDD9105E6964 Q47561285-B3256497-BAAF-41A9-BB9D-0A071644C9B9 Q52614385-454FE3C8-43C7-46B4-8491-A706C8489F27 Q55344788-56728C26-13F5-4B45-A5E5-BD5F039D5CA8 Q58797884-EC99ACB7-CD98-47F0-83D3-2CFF97A20266

P2860

Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction

http://www.wikidata.org/entity/Q28237208

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@ast

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@en

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@nl

type

label

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@ast

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@en

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@nl

prefLabel

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@ast

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@en

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@nl

P1433

Q28237208-5650811B-544A-4BA7-B16F-EFAF1EBD45FE

P1476

Q28237208-30FB1B6B-1264-44EB-8D08-B0CADA0839CF

P2093

Q28237208-18D951FF-3442-4740-854C-B4E4DF70856B

Q28237208-1BD7488E-D49A-4EDC-93D9-7EC13A9A6CAF

Q28237208-36363C66-ABF8-4E35-9134-AA92475C3FF1

Q28237208-49FCDD3C-2243-4369-A405-0F730ED55FFE

Q28237208-553F111F-2000-4435-9899-054BE13F28CC

Q28237208-66DC2676-D8B1-48F0-B8BD-75A4D2211127

Q28237208-679F425E-1B70-458E-8D4D-AF7E7A56E0CA

Q28237208-9026EFF9-6825-4BA7-A9BF-B753E3C8EA8A

Q28237208-A05830E6-2289-4989-9567-5C9BF6890209

Q28237208-C14ED0F6-9BEB-4EFA-AF37-E048D4F83CDC

P2860

Q28237208-11371A76-DB69-4F8A-BD60-56AF09FEAD8C

Q28237208-1E07AC31-F930-4C15-ACDB-913988252844

Q28237208-24C3D321-ACA8-4964-9DC3-B1A44052574C

Q28237208-275D2546-7AC2-4F78-B854-1C7457B35665

Q28237208-2B0FBF0F-379B-4598-8C8A-6A9C02D294CA

Q28237208-2BE37E48-4495-4811-9688-5A38334255AB

Q28237208-3A9E345F-D82B-4029-89DC-A911BF263245

Q28237208-450F8026-A458-4AE2-9C5A-B8D92EA51610

Q28237208-4816FEA6-2975-4979-B089-E1F175A41413

Q28237208-508C2EC4-7CCB-431B-B561-8FB8A2C2A963

P2888

Q28237208-271DA62D-DEF7-4647-A320-8228FEA8D5A7

P304

Q28237208-493AC437-0C60-47A5-B190-3E114B24FBA2

P31

Q28237208-44061076-509A-41EF-9FB6-318D872F909B

P3181

Q28237208-DB69E7EF-5724-4950-87E3-DBFCE37CF7A3

P356

Q28237208-821ACF74-4709-4ED9-8075-DFEE11219181

P407

Q28237208-9AB94690-E2FC-4042-8759-94D64DCD1ECA

P433

Q28237208-2CB94E3B-3FEA-4433-9312-1EC51473E14F

P478

Q28237208-5A9C0706-E319-4B84-B5E1-8B14232EC23C

P50

Q28237208-7BDAEA31-12E1-465C-BE23-8930FF0A61B2

P577

Q28237208-86C5F696-D5A7-443D-8EEE-38E55E82244C

P6179

Q28237208-5D88C280-D2C8-49A3-9C7F-B5A240D18598

P698

Q28237208-9B58DA6B-583E-4EA6-B07C-2461C3BDA773

P3181

P356

LABINVEST.2014.50

P1433

Laboratory Investigation

P1476

Dipeptidyl peptidase IV inhibi ...... model of ureteral obstruction

@en

P2093

Hye Kyoung Song

http://www.w3.org/2001/XMLSchema#string

Hye Sook Min

http://www.w3.org/2001/XMLSchema#string

Hyun Wook Kim

http://www.w3.org/2001/XMLSchema#string

Jee Young Han

http://www.w3.org/2001/XMLSchema#string

Ji Eun Lee

http://www.w3.org/2001/XMLSchema#string

Jin Joo Cha

http://www.w3.org/2001/XMLSchema#string

Jung Eun Kim

http://www.w3.org/2001/XMLSchema#string

Mi Hwa Lee

http://www.w3.org/2001/XMLSchema#string

Mi Jin Lee

http://www.w3.org/2001/XMLSchema#string

Young Sun Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy

Chronic unilateral ureteral obstruction in the neonatal mouse delays maturation of both kidneys and leads to late formation of atubular glomeruli

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.

Moonlighting proteins.

Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform.

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes.

P2888

labinvest.2014.50

P304

598-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2179912

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/LABINVEST.2014.50

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050254556

http://www.w3.org/2001/XMLSchema#string

P698

24687121

http://www.w3.org/2001/XMLSchema#string